Read the rest here: Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
Read the rest here: Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
See original here: Digicann Ventures Announces Granting of Forbearance for Convertible Debenture Maturity Date
Read more: TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
See the original post here: Common Skin Cancer, Like Christie Brinkley’s, Can Often Be Cured Without Surgery
Originally posted here: Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Read more here: Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million
Read the rest here: Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
Read more: Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
See more here: Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
Recent Comments